Health-related quality of life of patients with rheumatoid arthritis on tocilizumab, adalimumab, and etanercept in Saudi Arabia: a single-center cross-sectional study

Health-related quality of life of patients with rheumatoid arthritis on tocilizumab, adalimumab, and etanercept in Saudi Arabia: a single-center cross-sectional study

Purpose: The aim of this study was to assess the quality of life (QOL) of patients with rheumatoid arthritis (RA) on tocilizumab versus other commonly used monoclonal antibodies (mAbs) (e.g., adalimumab and etanercept).Methods: This was an interview-based cross-sectional study. Adult RA patients (≥1...

Full description

Bibliographic Details
Main Authors: Amjad M. Alotaibi, Areej S. Albahdal, Norah Abanmy, Monira Alwhaibi, Yousif Asiri, Yazed AlRuthia
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Pharmacology
Subjects:
monoclonal antibody therapy
Saudi Arabia
cross-sectional study
comparative effectiveness
health-related quality of life
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1299630/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1299630/full

Similar Items